ChartRow logo
Share this page
GH
$177.80+1.75%
as of close, Oct 2, 2026
☾ AH $177.80 +1.75%
PeersMRNALLYUNHJNJMRKTMO

GH financial statements

The full income statement, balance sheet, and cash-flow statement for Guardant Health Inc. (GH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 123.0M2024-09 123.6M2024-12 123.4M2025-03 123.9M2025-06 124.7M2025-09 126.0M2025-12 131.2M2026-03 132.6M2026-06 134.2M+9.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue982M+32.9%739M+31.0%564M+25.5%450M+20.3%374M+30.3%
Cost of revenue349M+20.4%290M+27.6%227M——
Research & development364M+4.7%348M-5.3%367M-1.8%374M+42.0%263M+75.6%
Selling, general & administrative211M+17.4%180M+15.6%156M-5.0%164M-20.7%207M+7.2%
General & administrative211M+17.4%180M+15.6%156M-5.0%164M-20.7%207M+7.2%
Selling & marketing495M+35.5%365M+23.6%295M-1.5%300M+56.3%192M+80.1%
Amortization of intangibles1.70M-22.7%2.20M-18.5%2.70M+8.0%2.50M+31.6%1.90M+5.6%
Operating income-437M+1.4%-444M+21.4%-565M-3.7%-544M-32.5%-411M-61.2%
Interest expense3.90M+51.0%2.58M+0.1%2.58M+0.0%2.58M+0.0%2.58M-45.9%
Interest & investment income34.1M-36.5%53.7M+51.8%35.4M+482.7%6.07M+54.4%3.93M-61.4%
Other non-operating income-10.5M+75.4%-42.6M-180.1%53.2M+516.1%-12.8M-150.8%25.2M+591.5%
Gain (loss) on equity securities0.00+100.0%-44.4M-155.7%79.7M+1122.8%-7.79M0.00
Pre-tax income-418M+4.0%-435M+9.1%-479M+26.7%-653M-70.0%-384M-56.3%
Income tax-1.26M-198.4%1.28M+87.4%685K-39.9%1.14M+279.7%300K-20.8%
-416M+4.6%-436M+9.0%-479M+26.8%-655M-70.1%-385M-56.2%
Net income to common-416M+4.6%-436M+9.0%-479M+26.8%-655M-61.4%-406M-59.8%
-$3.32+6.7%-$3.56+16.8%-$4.28+33.2%-$6.41-60.3%-$4.00-53.8%
EPS (basic)-$3.32+6.7%-$3.56+16.8%-$4.28+33.2%-$6.41-60.3%-$4.00-53.8%
Weighted-avg shares (basic)125M+2.1%123M+9.6%112M+9.6%102M+0.9%101M+3.9%
Weighted-avg shares (diluted)125M+2.1%123M+9.6%112M+9.6%102M+0.9%101M+3.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.47B+38.9%1.06B-21.7%1.35B+13.1%1.19B+7.0%1.11B-41.0%
Cash & equivalents378M-28.0%526M-53.6%1.13B+700.3%142M-71.2%492M-40.9%
Short-term investments———870M+97.4%441M-54.2%
Accounts receivable138M+25.0%110M+24.2%88.8M-8.7%97.3M-0.4%97.7M+83.2%
Inventory85.9M+20.8%71.1M+14.7%61.9M+20.1%51.6M+68.2%30.7M+35.0%
Prepaid expenses40.7M+20.5%33.8M+21.8%27.7M-12.0%31.5M-40.6%53.1M+203.7%
2.01B+35.5%1.49B-16.8%1.79B+11.0%1.61B-27.0%2.20B-3.0%
Property, plant & equipment146M+6.7%137M-5.7%145M-13.6%168M+34.9%124M+98.2%
Operating lease right-of-use159M+11.7%142M-9.7%158M-9.4%174M-8.2%189M+407.3%
Goodwill77.3M+2248.2%3.29M+0.0%3.29M+0.0%3.29M+0.0%3.29M+0.0%
Intangible assets25.9M+283.4%6.76M-24.7%8.98M-23.4%11.7M-17.5%14.2M-12.1%
Long-term investments———0.00-100.0%698M+183.1%
Other non-current assets28.5M-23.4%37.2M-70.1%124M+102.1%61.5M+0.8%60.9M+253.2%
303M+34.2%226M+9.6%206M+6.6%193M-0.8%195M+191.4%
Accounts payable54.4M+41.2%38.6M-25.5%51.7M-24.9%68.9M+78.9%38.5M+424.8%
Accrued liabilities77.9M+14.0%68.3M+7.7%63.5M-63.9%176M+288.2%45.3M+100.0%
Deferred revenue50.8M+43.1%35.5M+97.4%18.0M+3.2%17.4M+53.7%11.3M+32.5%
Current lease liability27.7M-5.3%29.2M+4.5%27.9M+27.8%21.9M+70.2%12.9M+93.8%
2.11B+30.0%1.63B-0.2%1.63B+5.0%1.55B-0.6%1.56B+70.2%
Long-term debt1.50B+31.6%1.14B———
Deferred revenue (non-current)9.00M+47.5%6.10M+22.0%5.00M+31.6%3.80M—
Non-current lease liability178M+8.6%164M-11.6%186M-11.5%210M-7.1%226M+443.9%
Operating lease liability (total)206M+6.5%194M-9.5%214M-7.8%232M-2.9%239M+395.7%
Other non-current liabilities128M+37.6%92.8M-3.3%96.0M+945.9%9.18M+133.4%3.93M+158.8%
-99.3M+28.9%-140M-188.0%159M+163.7%60.2M-90.7%645M-50.3%
Additional paid-in capital2.90B+18.7%2.44B+6.1%2.30B+32.3%1.74B+5.1%1.66B-12.9%
Retained earnings-2.99B-16.1%-2.58B-20.4%-2.14B-28.8%-1.66B-65.0%-1.01B-66.1%
Treasury stock
—0.00———
Accumulated other comprehensive income-4.85M+6.7%-5.20M-41.5%-3.67M+81.2%-19.5M-309.8%-4.76M-276.6%
Total liabilities & equity2.01B+35.5%1.49B-16.8%1.79B+11.0%1.61B-27.0%2.20B-3.0%
Common shares issued131M+5.4%124M+1.9%122M+18.5%103M+0.8%102M+1.6%
Common shares outstanding131M+5.4%124M+1.9%122M+18.5%103M+0.8%102M+1.6%
Shares outstanding (cover)131M+6.3%123M+1.4%122M+18.6%103M+0.8%102M+1.4%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-185M+23.0%-240M+26.2%-325M-5.0%-309M-48.1%-209M-101.1%
Depreciation & amortization39.7M-6.3%42.4M-1.2%42.9M+19.2%36.0M+61.5%22.3M+38.6%
Intangible amortization1.70M-22.7%2.20M-18.5%2.70M+8.0%2.50M+31.6%1.90M+5.6%
Share-based compensation166M+18.4%140M+54.7%90.8M-4.1%94.7M-37.5%151M+5.1%
Deferred income taxes-1.71M-694.1%287K+153.0%-541K-129.2%-236K-232.6%178K+34.8%
Change in receivables28.2M+31.7%21.4M+355.3%-8.38M-2134.1%-375K-100.8%44.4M+711.9%
Change in inventory14.8M+61.9%9.13M-11.7%10.3M-50.5%20.9M+163.0%7.96M+5.6%
Change in payables
————8.64M+209.9%
-627M-140.0%-261M-131.1%840M+460.9%150M+337.2%-63.2M+89.8%
Capital expenditure48.3M+37.7%35.1M+71.3%20.5M-73.6%77.5M+3.2%75.0M+107.4%
Free cash flow-233M+15.2%-275M+20.4%-345M+10.7%-387M-36.2%-284M-102.7%
Acquisitions59.0M0.000.000.000.00
Sales/maturities of investments307M+778.1%35.0M-97.7%1.49B+169.3%555M-41.7%952M
Other investing activities——-1.53M0.000.00
671M+67482.8%-996K-100.2%477M+352.5%-189M-183.0%-66.8M-104.7%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued257M0.00-100.0%493M0.000.00-100.0%
Common stock repurchased45.0M0.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities3.60M+2450.3%-153K-102.5%6.03M+630.6%-1.14M-22.2%-930K
Net change in cash-140M+72.2%-504M-150.8%992M+383.1%-350M-2.8%-341M-149.4%
Interest paid3.77M0.000.00—0.00
Income taxes paid869K-13.7%1.01M-48.9%1.97M+47.9%1.33M+238.7%393K+18.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap13.4B+255.3%3.77B+18.1%3.19B+14.6%2.79B-72.7%10.2B-21.3%
P/S13.6×+167.4%5.1×-14.4%6.0×-7.9%6.5×-76.3%27.3×-39.6%
P/B——14.0×-16.3%16.7×+5.8%15.8×+58.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: GH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GH filings on SEC EDGAR → Not investment advice.